About garadacimab
Monoclonal antibody; factor XIIa inhibitor
Used for
- Prevention of hereditary angioedema attacks in adults and adolescents.
Usual adult dose
Initial dose 400 mg under the skin, then 200 mg every two weeks.
Usual dose in children
For adolescents aged 12 years and older: same dose as adults. Not established for younger children.
Common side effects
- Injection-site reactions
- Headache
- Abdominal pain
Important warnings
- Not for treating an acute angioedema attack.
- Keep prescribed rescue treatment available for acute attacks.
- Serious allergic reactions, including anaphylaxis, may occur.
Pregnancy
Human pregnancy data are limited; use only when a clinician considers it necessary.
Breastfeeding
It is unknown whether garadacimab passes into breast milk; discuss use with a clinician.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.